Treatment of Persistent Distal Occlusion After Successful Proximal Recanalization in Thrombectomy
NCT: NCT06034847 · WITHDRAWN
Brief Summary
In stroke patients, mechanical thrombectomy is now the standard of care when the stroke is due to large proximal cerebral vessel occlusion. The purpose of the 2BE3 trial is to test whether adjunct rescue treatment of persisting distal occlusions after successful proximal recanalization of the large vessel occlusion can be proposed as an additional intervention to restore reperfusion of affected stroke tissue and improve clinical outcomes. The rescue therapies will be either mechanical (small stent retrievers and/or small aspiration catheters) or pharmacological (infusion of intra-arterial thrombolytics). Patients will be randomized to conservative management (mechanical thrombectomy with or without IV thrombolytics of large proximal vessels) or rescue therapy (mechanical or pharmacological interventions in distal vessels in addition to conservative management). Each patient will be followed for 3 months post-intervention. The data collected will be clinical assessments and angiographic imaging to evaluate the reperfusion state.
Frequently Asked Questions
What is Treatment of Persistent Distal Occlusion After Successful Proximal Recanalization in Thrombectomy?
Treatment of Persistent Distal Occlusion After Successful Proximal Recanalization in Thrombectomy is a clinical trial registered under NCT06034847. Current status: WITHDRAWN.
What is the status of NCT06034847?
The current status of NCT06034847 (Treatment of Persistent Distal Occlusion After Successful Proximal Recanalization in Thrombectomy) is: WITHDRAWN.
When did Treatment of Persistent Distal Occlusion After Successful Proximal Recanalization in Thrombectomy start?
Treatment of Persistent Distal Occlusion After Successful Proximal Recanalization in Thrombectomy started on 2024-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.